Orion Capital Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.89K Hold
23
﹤0.01% 412
2026
Q1
$6.73K Hold
23
﹤0.01% 385
2025
Q4
$8.06K Hold
23
﹤0.01% 399
2025
Q3
$7.43K Hold
23
﹤0.01% 408
2025
Q2
$8.95K Hold
23
﹤0.01% 369
2025
Q1
$10K Sell
23
-82
-78% -$32.9K ﹤0.01% 356
2024
Q4
$38.7K Buy
+105
New +$43.9K 0.02% 260
2024
Q3
Sell
-105
Closed -$56.9K 248
2024
Q2
$56.9K Hold
105
0.03% 218
2024
Q1
$54.4K Hold
105
0.03% 233
2023
Q4
$49.5K Hold
105
0.03% 242
2023
Q3
$45.7K Buy
+105
New +$47.6K 0.03% 237
2023
Q2
Sell
-112
Closed -$51.5K 238
2023
Q1
$51.5K Hold
112
0.03% 215
2022
Q4
$57.5K Hold
112
0.04% 189
2022
Q3
$51K Buy
+112
New +$53.6K 0.04% 192

Other funds holding ELV

Orion Capital Management's ELV Position: Q2 2026 in Review

Orion Capital Management held its Elevance Health (ELV) position steady in Q2 2026 at 23 shares worth $8.89K. The position accounts for ﹤0.01% of the portfolio, ranked #412.

Orion Capital Management first reported a position in ELV in Q3 2022 and has held it in 14 quarters since. The position peaked at $57.5K in Q4 2022. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Orion Capital Management held 23 shares of Elevance Health worth $8.89K as of Q2 2026.
  • Orion Capital Management left its Elevance Health share count unchanged in Q2 2026.
  • Elevance Health made up ﹤0.01% of Orion Capital Management's portfolio in Q2 2026, its #412 holding.
  • Orion Capital Management first reported a position in Elevance Health in Q3 2022 and has held it in 14 quarters since.
  • Orion Capital Management's Elevance Health position peaked at $57.5K in Q4 2022.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Orion Capital Management's 13F filing for Q2 2026, filed 18 Aug 2026.